Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bojke

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Applied Health Economics and Health Policy|March 14, 2014
Belief elicitation to populate health economic models of medical diagnostic devices in developmentWieke Haakma, Lotte M G Steuten, Laura Bojke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness AnalysesMarta O Soares, Linda Sharples, Alec Morton, et al.
Pharmacoeconomics|May 5, 2017
How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness AnalysisLaura Bojke, Andrea Manca, Miqdad Asaria, et al.
Pharmacoeconomics|May 19, 2006
Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trialLaura Bojke, Mark Sculpher, Richard Stephens, et al.
Pharmacoeconomics|June 16, 2017
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model UncertaintiesLaura Bojke, Bogdan Grigore, Dina Jankovic, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/Illa antagonists in non-ST elevation acute coronary syndromeZoë Philips, Karl Philip Claxton, Stephen Palmer, et al.
Statistics in Medicine|July 13, 2011
Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulcerationMarta O Soares, Laura Bojke, Jo Dumville, et al.
Pharmacoeconomics - Open|February 16, 2018
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery DiseaseJames Lomas, Miqdad Asaria, Laura Bojke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Eliciting distributions to populate decision analytic modelsLaura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
A framework for addressing structural uncertainty in decision modelsChristopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Applied Health Economics and Health Policy|March 14, 2014
Belief elicitation to populate health economic models of medical diagnostic devices in developmentWieke Haakma, Lotte M G Steuten, Laura Bojke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness AnalysesMarta O Soares, Linda Sharples, Alec Morton, et al.
Pharmacoeconomics|May 5, 2017
How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness AnalysisLaura Bojke, Andrea Manca, Miqdad Asaria, et al.
Pharmacoeconomics|May 19, 2006
Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trialLaura Bojke, Mark Sculpher, Richard Stephens, et al.
Pharmacoeconomics|June 16, 2017
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model UncertaintiesLaura Bojke, Bogdan Grigore, Dina Jankovic, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/Illa antagonists in non-ST elevation acute coronary syndromeZoë Philips, Karl Philip Claxton, Stephen Palmer, et al.
Statistics in Medicine|July 13, 2011
Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulcerationMarta O Soares, Laura Bojke, Jo Dumville, et al.
Pharmacoeconomics - Open|February 16, 2018
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery DiseaseJames Lomas, Miqdad Asaria, Laura Bojke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Eliciting distributions to populate decision analytic modelsLaura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 24, 2011
A framework for addressing structural uncertainty in decision modelsChristopher H Jackson, Laura Bojke, Simon G Thompson, et al.
Pageof 9